Full Press Release Details
Zymeworks Statement on U.S. Supreme Court Overturning Roe v. Wade.
ZYME
Zymeworks Statement on U.S. Supreme Court Overturning Roe v. Wade
Key Takeaway: Zymeworks Statement on U.S. Supreme Court Overturning Roe v. Wade
Price reaction · baseline $6.5 (2022-07-08 close) · clean, no other ZYME news in the window
day 0 close
-9.7%
day 1 · peak
-12.6%
day 3
-9.1%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+23%
120-day peak, hindsight
Typical move
5.4%
average across 7 past catalysts
Cash runway
~35 mo
Minimal dilution risk
Lead asset
ZW49
Phase 1 · HER2-expressing Cancers